【調査レポート】臨床開発サービス（CDS）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Clinical Development Services Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。臨床開発サービス（CDS）のグローバル市場インサイト・予測（～2028年） / Global Clinical Development Services Market Insights, Forecast to 2028 / QY2207C3855資料のイメージです。

• レポートコード：QY2207C3855
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、127ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の臨床開発サービス（CDS）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に臨床開発サービス（CDS）の世界市場のxxx％を占める「生物統計学」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬会社」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の臨床開発サービス（CDS）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの臨床開発サービス（CDS）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの臨床開発サービス（CDS）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

臨床開発サービス（CDS）のグローバル主要メーカーには、Syneos Health、PPD、GVI CDS、Parexel、Clinical Leader、Thermo Fisher Scientific、LabCorp、Worldwide Clinical Trial、CROS NT、Dynakin、Rho, Inc.、Synteract、ICBio CRO、Sofpromed、Profil、ICON plc、Clinipace、OCT Clinical、EPS Group、Beijing Sun-novo Pharmaceutical Research、Dmedglobal、WuXi AppTec、Elixir Clinical Research、IBMなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

臨床開発サービス（CDS）市場は、種類と用途によって区分されます。世界の臨床開発サービス（CDS）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
生物統計学、データ管理、臨床試験モニタリング、臨床試験プロジェクト管理（フェーズI-IV）、規制業務、ファーマコビジランス、その他

【用途別セグメント】
製薬会社、医療機器会社、委託研究機関

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 臨床開発サービス（CDS）製品概要
- 種類別市場（生物統計学、データ管理、臨床試験モニタリング、臨床試験プロジェクト管理（フェーズI-IV）、規制業務、ファーマコビジランス、その他）
- 用途別市場（製薬会社、医療機器会社、委託研究機関）
- 調査の目的
・エグゼクティブサマリー
- 世界の臨床開発サービス（CDS）販売量予測2017-2028
- 世界の臨床開発サービス（CDS）売上予測2017-2028
- 臨床開発サービス（CDS）の地域別販売量
- 臨床開発サービス（CDS）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別臨床開発サービス（CDS）販売量
- 主要メーカー別臨床開発サービス（CDS）売上
- 主要メーカー別臨床開発サービス（CDS）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（生物統計学、データ管理、臨床試験モニタリング、臨床試験プロジェクト管理（フェーズI-IV）、規制業務、ファーマコビジランス、その他）
- 臨床開発サービス（CDS）の種類別販売量
- 臨床開発サービス（CDS）の種類別売上
- 臨床開発サービス（CDS）の種類別価格
・用途別市場規模（製薬会社、医療機器会社、委託研究機関）
- 臨床開発サービス（CDS）の用途別販売量
- 臨床開発サービス（CDS）の用途別売上
- 臨床開発サービス（CDS）の用途別価格
・北米市場
- 北米の臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの臨床開発サービス（CDS）市場規模（種類別、用途別）
- 主要国別の臨床開発サービス（CDS）市場規模（トルコ、サウジアラビア）
・企業情報
Syneos Health、PPD、GVI CDS、Parexel、Clinical Leader、Thermo Fisher Scientific、LabCorp、Worldwide Clinical Trial、CROS NT、Dynakin、Rho, Inc.、Synteract、ICBio CRO、Sofpromed、Profil、ICON plc、Clinipace、OCT Clinical、EPS Group、Beijing Sun-novo Pharmaceutical Research、Dmedglobal、WuXi AppTec、Elixir Clinical Research、IBM
・産業チェーン及び販売チャネル分析
- 臨床開発サービス（CDS）の産業チェーン分析
- 臨床開発サービス（CDS）の原材料
- 臨床開発サービス（CDS）の生産プロセス
- 臨床開発サービス（CDS）の販売及びマーケティング
- 臨床開発サービス（CDS）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 臨床開発サービス（CDS）の産業動向
- 臨床開発サービス（CDS）のマーケットドライバー
- 臨床開発サービス（CDS）の課題
- 臨床開発サービス（CDS）の阻害要因
・主な調査結果

Market Analysis and Insights: Global Clinical Development Services Market
The global Clinical Development Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Biostatistics accounting for % of the Clinical Development Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical Companies segment is altered to an % CAGR throughout this forecast period.
China Clinical Development Services market size is valued at US$ million in 2021, while the North America and Europe Clinical Development Services are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Clinical Development Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Development Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Development Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Development Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Development Services market.
Global Clinical Development Services Scope and Market Size
Clinical Development Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Clinical Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Biostatistics
Data Management
Clinical Trial Monitoring
Clinical Trial Project Management (Phase I-Iv)
Regulatory Affairs
Pharmacovigilance
Other
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Contract Research Organizations
By Company
Syneos Health
PPD
GVI CDS
Parexel
Clinical Leader
Thermo Fisher Scientific
LabCorp
Worldwide Clinical Trial
CROS NT
Dynakin
Rho, Inc.
Synteract
ICBio CRO
Sofpromed
Profil
ICON plc
Clinipace
OCT Clinical
EPS Group
Beijing Sun-novo Pharmaceutical Research
Dmedglobal
WuXi AppTec
Elixir Clinical Research
IBM
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Development Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biostatistics
1.2.3 Data Management
1.2.4 Clinical Trial Monitoring
1.2.5 Clinical Trial Project Management (Phase I-Iv)
1.2.6 Regulatory Affairs
1.2.7 Pharmacovigilance
1.2.8 Other
1.3 Market by Application
1.3.1 Global Clinical Development Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Development Services Market Perspective (2017-2028)
2.2 Clinical Development Services Growth Trends by Region
2.2.1 Clinical Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical Development Services Historic Market Size by Region (2017-2022)
2.2.3 Clinical Development Services Forecasted Market Size by Region (2023-2028)
2.3 Clinical Development Services Market Dynamics
2.3.1 Clinical Development Services Industry Trends
2.3.2 Clinical Development Services Market Drivers
2.3.3 Clinical Development Services Market Challenges
2.3.4 Clinical Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Development Services Players by Revenue
3.1.1 Global Top Clinical Development Services Players by Revenue (2017-2022)
3.1.2 Global Clinical Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Clinical Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Development Services Revenue
3.4 Global Clinical Development Services Market Concentration Ratio
3.4.1 Global Clinical Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Development Services Revenue in 2021
3.5 Clinical Development Services Key Players Head office and Area Served
3.6 Key Players Clinical Development Services Product Solution and Service
3.7 Date of Enter into Clinical Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Development Services Breakdown Data by Type
4.1 Global Clinical Development Services Historic Market Size by Type (2017-2022)
4.2 Global Clinical Development Services Forecasted Market Size by Type (2023-2028)
5 Clinical Development Services Breakdown Data by Application
5.1 Global Clinical Development Services Historic Market Size by Application (2017-2022)
5.2 Global Clinical Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Development Services Market Size (2017-2028)
6.2 North America Clinical Development Services Market Size by Type
6.2.1 North America Clinical Development Services Market Size by Type (2017-2022)
6.2.2 North America Clinical Development Services Market Size by Type (2023-2028)
6.2.3 North America Clinical Development Services Market Share by Type (2017-2028)
6.3 North America Clinical Development Services Market Size by Application
6.3.1 North America Clinical Development Services Market Size by Application (2017-2022)
6.3.2 North America Clinical Development Services Market Size by Application (2023-2028)
6.3.3 North America Clinical Development Services Market Share by Application (2017-2028)
6.4 North America Clinical Development Services Market Size by Country
6.4.1 North America Clinical Development Services Market Size by Country (2017-2022)
6.4.2 North America Clinical Development Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Development Services Market Size (2017-2028)
7.2 Europe Clinical Development Services Market Size by Type
7.2.1 Europe Clinical Development Services Market Size by Type (2017-2022)
7.2.2 Europe Clinical Development Services Market Size by Type (2023-2028)
7.2.3 Europe Clinical Development Services Market Share by Type (2017-2028)
7.3 Europe Clinical Development Services Market Size by Application
7.3.1 Europe Clinical Development Services Market Size by Application (2017-2022)
7.3.2 Europe Clinical Development Services Market Size by Application (2023-2028)
7.3.3 Europe Clinical Development Services Market Share by Application (2017-2028)
7.4 Europe Clinical Development Services Market Size by Country
7.4.1 Europe Clinical Development Services Market Size by Country (2017-2022)
7.4.2 Europe Clinical Development Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Development Services Market Size (2017-2028)
8.2 Asia-Pacific Clinical Development Services Market Size by Type
8.2.1 Asia-Pacific Clinical Development Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical Development Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical Development Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical Development Services Market Size by Application
8.3.1 Asia-Pacific Clinical Development Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical Development Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical Development Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical Development Services Market Size by Region
8.4.1 Asia-Pacific Clinical Development Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical Development Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Development Services Market Size (2017-2028)
9.2 Latin America Clinical Development Services Market Size by Type
9.2.1 Latin America Clinical Development Services Market Size by Type (2017-2022)
9.2.2 Latin America Clinical Development Services Market Size by Type (2023-2028)
9.2.3 Latin America Clinical Development Services Market Share by Type (2017-2028)
9.3 Latin America Clinical Development Services Market Size by Application
9.3.1 Latin America Clinical Development Services Market Size by Application (2017-2022)
9.3.2 Latin America Clinical Development Services Market Size by Application (2023-2028)
9.3.3 Latin America Clinical Development Services Market Share by Application (2017-2028)
9.4 Latin America Clinical Development Services Market Size by Country
9.4.1 Latin America Clinical Development Services Market Size by Country (2017-2022)
9.4.2 Latin America Clinical Development Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Development Services Market Size (2017-2028)
10.2 Middle East & Africa Clinical Development Services Market Size by Type
10.2.1 Middle East & Africa Clinical Development Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical Development Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical Development Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical Development Services Market Size by Application
10.3.1 Middle East & Africa Clinical Development Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical Development Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical Development Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical Development Services Market Size by Country
10.4.1 Middle East & Africa Clinical Development Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical Development Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Syneos Health
11.1.1 Syneos Health Company Details
11.1.2 Syneos Health Business Overview
11.1.3 Syneos Health Clinical Development Services Introduction
11.1.4 Syneos Health Revenue in Clinical Development Services Business (2017-2022)
11.1.5 Syneos Health Recent Developments
11.2 PPD
11.2.1 PPD Company Details
11.2.2 PPD Business Overview
11.2.3 PPD Clinical Development Services Introduction
11.2.4 PPD Revenue in Clinical Development Services Business (2017-2022)
11.2.5 PPD Recent Developments
11.3 GVI CDS
11.3.1 GVI CDS Company Details
11.3.2 GVI CDS Business Overview
11.3.3 GVI CDS Clinical Development Services Introduction
11.3.4 GVI CDS Revenue in Clinical Development Services Business (2017-2022)
11.3.5 GVI CDS Recent Developments
11.4 Parexel
11.4.1 Parexel Company Details
11.4.2 Parexel Business Overview
11.4.3 Parexel Clinical Development Services Introduction
11.4.4 Parexel Revenue in Clinical Development Services Business (2017-2022)
11.4.5 Parexel Recent Developments
11.5 Clinical Leader
11.5.1 Clinical Leader Company Details
11.5.2 Clinical Leader Business Overview
11.5.3 Clinical Leader Clinical Development Services Introduction
11.5.4 Clinical Leader Revenue in Clinical Development Services Business (2017-2022)
11.5.5 Clinical Leader Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Clinical Development Services Introduction
11.6.4 Thermo Fisher Scientific Revenue in Clinical Development Services Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Clinical Development Services Introduction
11.7.4 LabCorp Revenue in Clinical Development Services Business (2017-2022)
11.7.5 LabCorp Recent Developments
11.8 Worldwide Clinical Trial
11.8.1 Worldwide Clinical Trial Company Details
11.8.2 Worldwide Clinical Trial Business Overview
11.8.3 Worldwide Clinical Trial Clinical Development Services Introduction
11.8.4 Worldwide Clinical Trial Revenue in Clinical Development Services Business (2017-2022)
11.8.5 Worldwide Clinical Trial Recent Developments
11.9 CROS NT
11.9.1 CROS NT Company Details
11.9.2 CROS NT Business Overview
11.9.3 CROS NT Clinical Development Services Introduction
11.9.4 CROS NT Revenue in Clinical Development Services Business (2017-2022)
11.9.5 CROS NT Recent Developments
11.10 Dynakin
11.10.1 Dynakin Company Details
11.10.2 Dynakin Business Overview
11.10.3 Dynakin Clinical Development Services Introduction
11.10.4 Dynakin Revenue in Clinical Development Services Business (2017-2022)
11.10.5 Dynakin Recent Developments
11.11 Rho, Inc.
11.11.1 Rho, Inc. Company Details
11.11.2 Rho, Inc. Business Overview
11.11.3 Rho, Inc. Clinical Development Services Introduction
11.11.4 Rho, Inc. Revenue in Clinical Development Services Business (2017-2022)
11.11.5 Rho, Inc. Recent Developments
11.12 Synteract
11.12.1 Synteract Company Details
11.12.2 Synteract Business Overview
11.12.3 Synteract Clinical Development Services Introduction
11.12.4 Synteract Revenue in Clinical Development Services Business (2017-2022)
11.12.5 Synteract Recent Developments
11.13 ICBio CRO
11.13.1 ICBio CRO Company Details
11.13.2 ICBio CRO Business Overview
11.13.3 ICBio CRO Clinical Development Services Introduction
11.13.4 ICBio CRO Revenue in Clinical Development Services Business (2017-2022)
11.13.5 ICBio CRO Recent Developments
11.14 Sofpromed
11.14.1 Sofpromed Company Details
11.14.2 Sofpromed Business Overview
11.14.3 Sofpromed Clinical Development Services Introduction
11.14.4 Sofpromed Revenue in Clinical Development Services Business (2017-2022)
11.14.5 Sofpromed Recent Developments
11.15 Profil
11.15.1 Profil Company Details
11.15.2 Profil Business Overview
11.15.3 Profil Clinical Development Services Introduction
11.15.4 Profil Revenue in Clinical Development Services Business (2017-2022)
11.15.5 Profil Recent Developments
11.16 ICON plc
11.16.1 ICON plc Company Details
11.16.2 ICON plc Business Overview
11.16.3 ICON plc Clinical Development Services Introduction
11.16.4 ICON plc Revenue in Clinical Development Services Business (2017-2022)
11.16.5 ICON plc Recent Developments
11.17 Clinipace
11.17.1 Clinipace Company Details
11.17.2 Clinipace Business Overview
11.17.3 Clinipace Clinical Development Services Introduction
11.17.4 Clinipace Revenue in Clinical Development Services Business (2017-2022)
11.17.5 Clinipace Recent Developments
11.18 OCT Clinical
11.18.1 OCT Clinical Company Details
11.18.2 OCT Clinical Business Overview
11.18.3 OCT Clinical Clinical Development Services Introduction
11.18.4 OCT Clinical Revenue in Clinical Development Services Business (2017-2022)
11.18.5 OCT Clinical Recent Developments
11.19 EPS Group
11.19.1 EPS Group Company Details
11.19.2 EPS Group Business Overview
11.19.3 EPS Group Clinical Development Services Introduction
11.19.4 EPS Group Revenue in Clinical Development Services Business (2017-2022)
11.19.5 EPS Group Recent Developments
11.20 Beijing Sun-novo Pharmaceutical Research
11.20.1 Beijing Sun-novo Pharmaceutical Research Company Details
11.20.2 Beijing Sun-novo Pharmaceutical Research Business Overview
11.20.3 Beijing Sun-novo Pharmaceutical Research Clinical Development Services Introduction
11.20.4 Beijing Sun-novo Pharmaceutical Research Revenue in Clinical Development Services Business (2017-2022)
11.20.5 Beijing Sun-novo Pharmaceutical Research Recent Developments
11.21 Dmedglobal
11.21.1 Dmedglobal Company Details
11.21.2 Dmedglobal Business Overview
11.21.3 Dmedglobal Clinical Development Services Introduction
11.21.4 Dmedglobal Revenue in Clinical Development Services Business (2017-2022)
11.21.5 Dmedglobal Recent Developments
11.22 WuXi AppTec
11.22.1 WuXi AppTec Company Details
11.22.2 WuXi AppTec Business Overview
11.22.3 WuXi AppTec Clinical Development Services Introduction
11.22.4 WuXi AppTec Revenue in Clinical Development Services Business (2017-2022)
11.22.5 WuXi AppTec Recent Developments
11.23 Elixir Clinical Research
11.23.1 Elixir Clinical Research Company Details
11.23.2 Elixir Clinical Research Business Overview
11.23.3 Elixir Clinical Research Clinical Development Services Introduction
11.23.4 Elixir Clinical Research Revenue in Clinical Development Services Business (2017-2022)
11.23.5 Elixir Clinical Research Recent Developments
11.24 IBM
11.24.1 IBM Company Details
11.24.2 IBM Business Overview
11.24.3 IBM Clinical Development Services Introduction
11.24.4 IBM Revenue in Clinical Development Services Business (2017-2022)
11.24.5 IBM Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Clinical Development Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biostatistics
Table 3. Key Players of Data Management
Table 4. Key Players of Clinical Trial Monitoring
Table 5. Key Players of Clinical Trial Project Management (Phase I-Iv)
Table 6. Key Players of Regulatory Affairs
Table 7. Key Players of Pharmacovigilance
Table 8. Key Players of Other
Table 9. Global Clinical Development Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Clinical Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Clinical Development Services Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Clinical Development Services Market Share by Region (2017-2022)
Table 13. Global Clinical Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Clinical Development Services Market Share by Region (2023-2028)
Table 15. Clinical Development Services Market Trends
Table 16. Clinical Development Services Market Drivers
Table 17. Clinical Development Services Market Challenges
Table 18. Clinical Development Services Market Restraints
Table 19. Global Clinical Development Services Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Clinical Development Services Revenue Share by Players (2017-2022)
Table 21. Global Top Clinical Development Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Development Services as of 2021)
Table 22. Ranking of Global Top Clinical Development Services Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Clinical Development Services Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Clinical Development Services Product Solution and Service
Table 26. Date of Enter into Clinical Development Services Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Clinical Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Clinical Development Services Revenue Market Share by Type (2017-2022)
Table 30. Global Clinical Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Clinical Development Services Revenue Market Share by Type (2023-2028)
Table 32. Global Clinical Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Clinical Development Services Revenue Share by Application (2017-2022)
Table 34. Global Clinical Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Clinical Development Services Revenue Share by Application (2023-2028)
Table 36. North America Clinical Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Clinical Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Clinical Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Clinical Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Clinical Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Clinical Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Clinical Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Clinical Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Clinical Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Clinical Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Clinical Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Clinical Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Clinical Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Clinical Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Clinical Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Clinical Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Clinical Development Services Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Clinical Development Services Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Clinical Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Clinical Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Clinical Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Clinical Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Clinical Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Clinical Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Clinical Development Services Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Clinical Development Services Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Clinical Development Services Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Clinical Development Services Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Clinical Development Services Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Clinical Development Services Market Size by Country (2023-2028) & (US$ Million)
Table 66. Syneos Health Company Details
Table 67. Syneos Health Business Overview
Table 68. Syneos Health Clinical Development Services Product
Table 69. Syneos Health Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 70. Syneos Health Recent Developments
Table 71. PPD Company Details
Table 72. PPD Business Overview
Table 73. PPD Clinical Development Services Product
Table 74. PPD Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 75. PPD Recent Developments
Table 76. GVI CDS Company Details
Table 77. GVI CDS Business Overview
Table 78. GVI CDS Clinical Development Services Product
Table 79. GVI CDS Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 80. GVI CDS Recent Developments
Table 81. Parexel Company Details
Table 82. Parexel Business Overview
Table 83. Parexel Clinical Development Services Product
Table 84. Parexel Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 85. Parexel Recent Developments
Table 86. Clinical Leader Company Details
Table 87. Clinical Leader Business Overview
Table 88. Clinical Leader Clinical Development Services Product
Table 89. Clinical Leader Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 90. Clinical Leader Recent Developments
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Clinical Development Services Product
Table 94. Thermo Fisher Scientific Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 95. Thermo Fisher Scientific Recent Developments
Table 96. LabCorp Company Details
Table 97. LabCorp Business Overview
Table 98. LabCorp Clinical Development Services Product
Table 99. LabCorp Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 100. LabCorp Recent Developments
Table 101. Worldwide Clinical Trial Company Details
Table 102. Worldwide Clinical Trial Business Overview
Table 103. Worldwide Clinical Trial Clinical Development Services Product
Table 104. Worldwide Clinical Trial Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 105. Worldwide Clinical Trial Recent Developments
Table 106. CROS NT Company Details
Table 107. CROS NT Business Overview
Table 108. CROS NT Clinical Development Services Product
Table 109. CROS NT Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 110. CROS NT Recent Developments
Table 111. Dynakin Company Details
Table 112. Dynakin Business Overview
Table 113. Dynakin Clinical Development Services Product
Table 114. Dynakin Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 115. Dynakin Recent Developments
Table 116. Rho, Inc. Company Details
Table 117. Rho, Inc. Business Overview
Table 118. Rho, Inc. Clinical Development Services Product
Table 119. Rho, Inc. Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 120. Rho, Inc. Recent Developments
Table 121. Synteract Company Details
Table 122. Synteract Business Overview
Table 123. Synteract Clinical Development Services Product
Table 124. Synteract Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 125. Synteract Recent Developments
Table 126. ICBio CRO Company Details
Table 127. ICBio CRO Business Overview
Table 128. ICBio CRO Clinical Development Services Product
Table 129. ICBio CRO Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 130. ICBio CRO Recent Developments
Table 131. Sofpromed Company Details
Table 132. Sofpromed Business Overview
Table 133. Sofpromed Clinical Development Services Product
Table 134. Sofpromed Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 135. Sofpromed Recent Developments
Table 136. Profil Company Details
Table 137. Profil Business Overview
Table 138. Profil Clinical Development Services Product
Table 139. Profil Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 140. Profil Recent Developments
Table 141. ICON plc Company Details
Table 142. ICON plc Business Overview
Table 143. ICON plc Clinical Development Services Product
Table 144. ICON plc Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 145. ICON plc Recent Developments
Table 146. Clinipace Company Details
Table 147. Clinipace Business Overview
Table 148. Clinipace Clinical Development Services Product
Table 149. Clinipace Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 150. Clinipace Recent Developments
Table 151. OCT Clinical Company Details
Table 152. OCT Clinical Business Overview
Table 153. OCT Clinical Clinical Development Services Product
Table 154. OCT Clinical Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 155. OCT Clinical Recent Developments
Table 156. EPS Group Company Details
Table 157. EPS Group Business Overview
Table 158. EPS Group Clinical Development Services Product
Table 159. EPS Group Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 160. EPS Group Recent Developments
Table 161. Beijing Sun-novo Pharmaceutical Research Company Details
Table 162. Beijing Sun-novo Pharmaceutical Research Business Overview
Table 163. Beijing Sun-novo Pharmaceutical Research Clinical Development Services Product
Table 164. Beijing Sun-novo Pharmaceutical Research Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 165. Beijing Sun-novo Pharmaceutical Research Recent Developments
Table 166. Dmedglobal Company Details
Table 167. Dmedglobal Business Overview
Table 168. Dmedglobal Clinical Development Services Product
Table 169. Dmedglobal Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 170. Dmedglobal Recent Developments
Table 171. WuXi AppTec Company Details
Table 172. WuXi AppTec Business Overview
Table 173. WuXi AppTec Clinical Development Services Product
Table 174. WuXi AppTec Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 175. WuXi AppTec Recent Developments
Table 176. Elixir Clinical Research Company Details
Table 177. Elixir Clinical Research Business Overview
Table 178. Elixir Clinical Research Clinical Development Services Product
Table 179. Elixir Clinical Research Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 180. Elixir Clinical Research Recent Developments
Table 181. IBM Company Details
Table 182. IBM Business Overview
Table 183. IBM Clinical Development Services Product
Table 184. IBM Revenue in Clinical Development Services Business (2017-2022) & (US$ Million)
Table 185. IBM Recent Developments
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Development Services Market Share by Type: 2021 VS 2028
Figure 2. Biostatistics Features
Figure 3. Data Management Features
Figure 4. Clinical Trial Monitoring Features
Figure 5. Clinical Trial Project Management (Phase I-Iv) Features
Figure 6. Regulatory Affairs Features
Figure 7. Pharmacovigilance Features
Figure 8. Other Features
Figure 9. Global Clinical Development Services Market Share by Application: 2021 VS 2028
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. Contract Research Organizations Case Studies
Figure 13. Clinical Development Services Report Years Considered
Figure 14. Global Clinical Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Clinical Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Clinical Development Services Market Share by Region: 2021 VS 2028
Figure 17. Global Clinical Development Services Market Share by Players in 2021
Figure 18. Global Top Clinical Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Development Services as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Clinical Development Services Revenue in 2021
Figure 20. North America Clinical Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Clinical Development Services Market Size Market Share by Type (2017-2028)
Figure 22. North America Clinical Development Services Market Size Market Share by Application (2017-2028)
Figure 23. North America Clinical Development Services Market Size Share by Country (2017-2028)
Figure 24. United States Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Clinical Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Clinical Development Services Market Size Market Share by Type (2017-2028)
Figure 28. Europe Clinical Development Services Market Size Market Share by Application (2017-2028)
Figure 29. Europe Clinical Development Services Market Size Share by Country (2017-2028)
Figure 30. Germany Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Clinical Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Clinical Development Services Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Clinical Development Services Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Clinical Development Services Market Size Share by Region (2017-2028)
Figure 40. China Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Clinical Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Clinical Development Services Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Clinical Development Services Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Clinical Development Services Market Size Share by Country (2017-2028)
Figure 50. Mexico Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Clinical Development Services Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Clinical Development Services Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Clinical Development Services Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Clinical Development Services Market Size Share by Country (2017-2028)
Figure 56. Turkey Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Clinical Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Syneos Health Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 60. PPD Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 61. GVI CDS Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 62. Parexel Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 63. Clinical Leader Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 65. LabCorp Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 66. Worldwide Clinical Trial Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 67. CROS NT Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 68. Dynakin Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 69. Rho, Inc. Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 70. Synteract Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 71. ICBio CRO Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 72. Sofpromed Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 73. Profil Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 74. ICON plc Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 75. Clinipace Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 76. OCT Clinical Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 77. EPS Group Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 78. Beijing Sun-novo Pharmaceutical Research Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 79. Dmedglobal Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 80. WuXi AppTec Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 81. Elixir Clinical Research Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 82. IBM Revenue Growth Rate in Clinical Development Services Business (2017-2022)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

以下、関連資料のご紹介

CD47（IAP）のグローバル市場インサイト・予測（～2028年）

Global CD47 (IAP) Market Insights, Forecast to 2028
QY2207C3850 2022年7月11日 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のCD47（IAP）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にCD47（IAP）...

バイオセーフティ試験サービス（BTS）のグローバル市場インサイト・予測（～2028年）

Global Biosafety Testing Service (BTS) Market Insights, Forecast to 2028
MRC2Q12-16734 2022年12月 112Pages
コロナ禍により、バイオセーフティ試験サービス（BTS）の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にバイオセーフティ試験サービス（...

分散型臨床試験（DCT）の世界市場2023年：インターベンショナル、オブザーバー、エクスパンデッドアクセス

Global Decentralized Clinical Trials (DCTs) Market Research Report 2023
MRC23Q35931 2023年3月 92Pages
本調査レポートは世界の分散型臨床試験（DCT）市場について調査・分析し、世界の分散型臨床試験（DCT）市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（インターベンショナル、オブザーバー、エクスパンデッドアクセス）、用途別セグメント分析（がん、循環器、その他）、地域別市場規模、主要...

ファーマコゲノミクス技術（セラノスティクス・CDx）のグローバル市場インサイト・予測（～2028年）

Global Pharmacogenomics Technology (Theranostics & CDx) Market Insights and Forecast to 2028
QY2203B05259 2022年3月11日 106Pages
新型コロナウイルス感染症のパンデミックにより、世界のファーマコゲノミクス技術（セラノスティクス・CDx）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮する...

脂質ナノ粒子（LNP）のグローバル市場インサイト・予測（～2028年）

Global Lipid Nanoparticles (LNP) Market Insights, Forecast to 2028
QY2203B09959 2022年3月11日 89Pages
新型コロナウイルス感染症のパンデミックにより、世界の脂質ナノ粒子（LNP）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脂質ナノ粒子（...